← Eichor
Condition: Non Hiv Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Non Hiv

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures
Phase N/A · 1 location(s) · University Hospital, Limoges · NCT05361603Zn Supplementation in HIV Immunological Non Responders
NA · 1 location(s) · Parc de Salut Mar · NCT06612554Blood Collection Biorepository for Liver Disease Research
Phase N/A · 1 location(s) · State University of New York at Buffalo · NCT03025074Outcomes of the PLHIV With Suboptimal Viral Suppression to Injectable Long-acting Antiretrovirals
Phase 3 · 4 location(s) · Chang Gung Memorial Hospital · NCT06507059Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
Phase 1 · 7 location(s) · AIDS Malignancy Consortium · NCT05077527The LD Lync Study - Natural History Study of Lipodystrophy Syndromes
Phase N/A · 4 location(s) · University of Michigan · NCT03087253Exploration of the Variability of Exposure to Antiretroviral Treatment in Hair With a View to Validating Its Value as a
Phase N/A · 1 location(s) · University Hospital, Toulouse · NCT07062614A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT06736613SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era
Phase N/A · 1 location(s) · University of California, San Francisco · NCT00187512Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease
Phase N/A · 1 location(s) · Peking Union Medical College Hospital · NCT05330923A Registry Study on HIV-related Lymphoma
Phase N/A · 6 location(s) · Rotkreuzklinikum München gGmbH · NCT05231135Optimization of Antiretroviral Therapy in Patients With AIDS-Related Lymphoma
NA · 1 location(s) · Shanghai Public Health Clinical Center · NCT07727642Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Phase N/A · 8 location(s) · AIDS Malignancy Consortium · NCT05663502Natural History of KSHV-Associated Multicentric Castleman s Disease
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT04968288Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cance
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT00006518Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Versus Darunavir/Cobicistat Plus Tenofovir/Emtricitabin
Phase 4 · 1 location(s) · José Antonio Mata Marín · NCT06907056The Implementation of Pre-exposure Prophylaxis of Injectable Cabotegravir
Phase 3 · 1 location(s) · Evandro Chagas National Institute of Infectious Disease · NCT05515770Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants
Phase 2 · 2 location(s) · Frantz Viral Therapeutics, LLC · NCT06206564Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT05389423Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment
NA · 5 location(s) · Johns Hopkins University · NCT05671718Targeted Therapies for Immunological Non-Responders in People With HIV: A Multicenter Clinical Study
Phase 2 · 5 location(s) · Beijing 302 Hospital · NCT07637877Acceptability and Feasibility of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users and Vulnerable
Phase N/A · 1 location(s) · University Hospital, Limoges · NCT06904820Cardiovascular Risk in Children With Chronic Conditions Study
Phase N/A · 3 location(s) · Semmelweis University · NCT07086989This Study Evaluates the ALPCO Syphilis-T and Syphilis-NT CLIA Kits for Detecting Syphilis Antibodies in Serum and Plasm
Phase N/A · 6 location(s) · American Laboratory Products Company · NCT07089836Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and I
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT07308886Safety and Immunogenicity Following Meningococcal and Pneumococcal Immunization Among Adult People Living With HIV
Phase 4 · 1 location(s) · Thomas Benfield · NCT04875819Virtual Reality (VR) Self-Hypnosis Software
NA · 1 location(s) · Icahn School of Medicine at Mount Sinai · NCT06398847ImPrEP LEN Brasil: Twice-Yearly Lenacapavir for HIV Prevention
NA · 8 location(s) · Oswaldo Cruz Foundation · NCT07497594Efficacy, Safety, and ToLerability of Switching to A Two-Drug Regimen With DTG/3TC Compared to Maintaining A Three-Drug
Phase 4 · 1 location(s) · José Antonio Mata Marín · NCT07138144Study of a Cohort of Non-HIV Immunocompromised Patients With Toxoplasmosis at the Strasbourg University Hospital
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT07299500
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.